|
MRPL18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.19889999997625E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.037600E-03 |
| Normal-vs-Stage2 |
3.239800E-02 |
| Normal-vs-Stage3 |
5.351900E-04 |
| Normal-vs-Stage4 |
4.380200E-03 |
| Stage1-vs-Stage2 |
2.855000E-01 |
| Stage1-vs-Stage3 |
2.060200E-02 |
| Stage1-vs-Stage4 |
1.186060E-02 |
| Stage2-vs-Stage3 |
4.400600E-01 |
| Stage2-vs-Stage4 |
1.442420E-02 |
| Stage3-vs-Stage4 |
2.747700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28479999997422E-06 |
| Normal-vs-AfricanAmerican |
4.560100E-04 |
| Normal-vs-Asian |
1.690430E-01 |
| Caucasian-vs-AfricanAmerican |
8.452400E-01 |
| Caucasian-vs-Asian |
2.138800E-01 |
| AfricanAmerican-vs-Asian |
2.373400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.08410000046966E-07 |
| Normal-vs-Female |
4.943000E-03 |
| Male-vs-Female |
4.878000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.580500E-03 |
| Normal-vs-Extreme_Weight |
1.323840E-03 |
| Normal-vs-Obese |
9.364900E-04 |
| Normal-vs-Extreme_Obese |
2.145200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.810800E-01 |
| Normal_Weight-vs-Obese |
8.212200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.115000E-01 |
| Extreme_Weight-vs-Obese |
3.331800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.054600E-01 |
| Obese-vs-Extreme_Obese |
9.839800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.961000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.49930000004073E-06 |
| Normal-vs-Age(61-80Yrs) |
7.590300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.422800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.462000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.398060E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.700270E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.026400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.046400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.08149999955565E-07 |
| Normal-VS-Type2 PRCC |
2.192300E-02 |
| Normal-VS-KIRP CIMP |
8.262200E-03 |
| Normal-VS-Unclassified PRCC |
2.662000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.670200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.348400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.579630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.310000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.551400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.694480E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.174250E-02 |
| Normal-vs-N1 |
9.93150000000442E-05 |
| Normal-vs-N2 |
2.823200E-01 |
| N0-vs-N1 |
2.525000E-03 |
| N0-vs-N2 |
7.375600E-02 |
| N1-vs-N2 |
2.060400E-02 |
|
|
